Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention.
about
Driving with no brakes: molecular pathophysiology of Kv7 potassium channelsThe acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytesFrom pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl groupNoise-induced plasticity of KCNQ2/3 and HCN channels underlies vulnerability and resilience to tinnitus.Kcnq1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish.Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels.Expression and function of the K+ channel KCNQ genes in human arteries.Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscleChemical control of metabolically-engineered voltage-gated K+ channels.Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels.Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.Adenosine relaxation in isolated rat aortic rings and possible roles of smooth muscle Kv channels, KATP channels and A2a receptorsUnexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 yearsPotassium and ANO1/ TMEM16A chloride channel profiles distinguish atypical and typical smooth muscle cells from interstitial cells in the mouse renal pelvisTargeted STIM deletion impairs calcium homeostasis, NFAT activation, and growth of smooth muscle.KV7 channels contribute to paracrine, but not metabolic or ischemic, regulation of coronary vascular reactivity in swineFunctional effects of KCNQ K(+) channels in airway smooth muscleAffinity for phosphatidylinositol 4,5-bisphosphate determines muscarinic agonist sensitivity of Kv7 K+ channels.Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles.KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries.Lidocaine relaxation in isolated rat aortic rings is enhanced by endothelial removal: possible role of Kv, KATP channels and A2a receptor crosstalk.Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats.Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy.Role of vascular potassium channels in the regulation of renal hemodynamics.Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.Role of renal vascular potassium channels in physiology and pathophysiology.Comparison of Voltage Gated K+ Currents in Arterial Myocytes with Heterologously Expressed K v Subunits.Targeting of Kv7.5 (KCNQ5)/KCNE channels to surface microdomains of cell membranes.Protein kinase C-independent inhibition of arterial smooth muscle K(+) channels by a diacylglycerol analogue.Interplay among distinct Ca2+ conductances drives Ca2+ sparks/spontaneous transient outward currents in rat cerebral arteries.Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection.The Kv7 Channel and Cardiovascular Risk Factors.Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone.Do KV 7.1 channels contribute to control of arterial vascular tone?The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia.
P2860
Q27023978-C236BC98-F54A-40DA-BCBC-D49F74991492Q28472214-EB034874-E8B6-43F7-8A78-DA5482C408ACQ28539924-A688A887-46DE-4863-8C96-9A4AAA10CD31Q30401440-FFF272BA-C403-4FDC-BD93-756D0CA09FDBQ30438624-833798B7-8235-4F73-8C9F-5982E4BA57EFQ34317893-2FADF6A1-D4C7-4007-A553-512E76550180Q34449702-658874CA-833F-46DE-BA0C-3AC52904F350Q35000941-8557111B-2CE1-4B32-A2BB-00D12ABAC188Q35165386-E0A0C5F7-D142-4DD7-B755-0AD4A084A8F1Q35593089-0CBE4AAC-5F83-4BF2-8BCD-273045058D77Q35950205-7155D4A4-69CE-4B3B-A794-9B50B9130741Q36025879-B0AC1BFA-002A-4CE7-9AA1-6E5CBB774AB7Q36111238-83954764-93B6-406F-A0C0-60A5DF82B2FBQ36147366-536BD566-6320-4AC7-A843-B046C72D3647Q36615175-DEBEA784-C930-47A8-90F7-A41DA704BD5FQ36895771-DF273A0C-94E4-4761-83D5-3AE8691C93D5Q37217408-3A71327D-B017-4CA3-A63A-4C67D79D52EFQ37402286-16D3A20A-BB42-49C1-8D43-ADF25A54A0A4Q37415814-57E47A83-B04A-4A56-9ACC-34438507210DQ37418220-A16CDC8A-88C1-4DB0-8C14-ACDB18EECD51Q37470421-807979B9-8252-4454-8E80-355BD6008765Q37589301-51946B29-AA67-465D-9A04-353FEE1EEBD3Q37781356-728DEC91-6BDB-4E49-877D-9DF8834E8D7FQ37968360-01055354-B80A-4244-8C10-E854D77EBAE4Q39141080-E16F5E90-7A39-4190-88D0-BAD9BE2E87C0Q39195631-ABFCFC34-FA06-48C6-880F-8F80065260DEQ39216726-755FBA19-E846-4D4D-8B33-D4C8CEBB0273Q39380245-797E04AB-478C-46CB-82B7-7C3B07C40198Q39424199-3CB57CD2-955D-4655-BE8F-6A4BB68D7423Q41834827-8CDB7DE4-409A-48D3-89DE-91778D0884DAQ43756991-78EB63DB-ED7B-492A-A0B4-D834A9A74CF7Q46616544-F26A42A9-DFC6-4824-A64A-EC64A2D4923EQ47098209-39F39785-0B53-45AB-92E8-064FC8AFCB6FQ47701761-A46F2BD7-907A-4EB9-99D2-C285EE705594Q49924020-978E6AC9-89DC-4518-A493-5BE1F449DC1AQ52631138-003991F0-C7D5-4BD6-BAB7-A5F4229D8D24
P2860
Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular KCNQ (Kv7) pota ...... for therapeutic intervention.
@en
Cardiovascular KCNQ
@nl
type
label
Cardiovascular KCNQ (Kv7) pota ...... for therapeutic intervention.
@en
Cardiovascular KCNQ
@nl
prefLabel
Cardiovascular KCNQ (Kv7) pota ...... for therapeutic intervention.
@en
Cardiovascular KCNQ
@nl
P356
P1476
Cardiovascular KCNQ (Kv7) pota ...... s for therapeutic intervention
@en
P2093
Alexander R Mackie
P304
P356
10.1124/MOL.108.049825
P577
2008-08-06T00:00:00Z